| | |
| Clinical data | |
|---|---|
| Trade names | Lenen, Novoderm, Varlane, Vaspit |
| Other names | FCB; SHK-203; Fluocortin 21-butylate; Fluocortin butylate; Fluocortolone-21-carboxylate 21-butyl; 6α-Fluoro-11β-hydroxy-16α-methyl-3,20-dioxopregna-1,4-dien-21-oic acid butyl ester |
| Drug class | Corticosteroid; Glucocorticoid |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.050.476 |
| Chemical and physical data | |
| Formula | C26H35FO5 |
| Molar mass | 446.559 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Fluocortin butyl (brand names Lenen, Novoderm, Varlane, Vaspit), or fluocortin 21-butylate, is a synthetic glucocorticoid corticosteroid which is marketed in Germany, Belgium, Luxembourg, Spain, and Italy. [1] [2] Chemically, it is the butyl ester derivative of fluocortin. [1] [2]
It was patented in 1971 and approved for medical use in 1977. [3]